Aileron Therapeutics Inc (NAS:ALRN)
$ 2.87 0.03 (1.06%) Market Cap: 61.96 Mil Enterprise Value: 44.70 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 42/100

Q3 2019 Aileron Therapeutics Inc Earnings Call Transcript

Nov 07, 2019 / 01:30PM GMT
Release Date Price: $10.4 (-7.70%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Aileron Therapeutics Third Quarter 2019 Financial and Operational Update.

(Operator Instructions) I must advise you all that the conference today is being recorded. I'd like to turn the call over to Rick Wanstall, Head of Finances at Aileron Therapeutics. Please go ahead, sir.

Richard J. Wanstall
Aileron Therapeutics, Inc. - VP of Finance & Operations, Principal Financial Officer and Principal Accounting Officer

Thank you, operator, and thank you, everyone, for joining us for the Aileron Therapeutics Third Quarter 2019 Update call today.

Before turning the call over to our President and CEO, Manuel Aivado, I would like to take a minute to remind you that this conference call and webcast will contain forward-looking statements that represent the company's intentions, expectations or beliefs concerning future events. These forward-looking statements are qualified by important factors set forth in today's press release and the company's filings with the SEC, which could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot